

According to our latest research, the global Heart-on-a-chip market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.
By "Heart-on-a-chip" technology - simulating the human heart on an engineering chip and using microelectrodes to measure the effects of compound exposure, it is possible to ensure that potential life-saving new drugs are safe and effective, while reducing the need for humans and animal testing.
The Heart-on-a-chip market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Heart-on-a-chip market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Children Heart-on-a-chip
Adult Heart-on-a-chip
Market segment by Application, can be divided into
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
Market segment by players, this report covers
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Tara Biosystems
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Heart-on-a-chip product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Heart-on-a-chip, with recent developments and future plans
Chapter 3, the Heart-on-a-chip competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Heart-on-a-chip market forecast, by regions, with revenue, from 2024 to 2030.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.
Chapter 7 and 8, to describe Heart-on-a-chip research findings and conclusion, appendix and data source.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Heart-on-a-chip
1.2 Classification of Heart-on-a-chip by Type
1.2.1 Overview: Global Heart-on-a-chip Market Size by Type: 2024 Versus 2030
1.2.2 Global Heart-on-a-chip Revenue Market Share by Type in 2030
1.2.3 Children Heart-on-a-chip
1.2.4 Adult Heart-on-a-chip
1.3 Global Heart-on-a-chip Market by Application
1.3.1 Overview: Global Heart-on-a-chip Market Size by Application: 2024 Versus 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Global Heart-on-a-chip Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Heart-on-a-chip Market Drivers
1.5.2 Heart-on-a-chip Market Restraints
1.5.3 Heart-on-a-chip Trends Analysis
2 Company Profiles
2.1 Emulate
2.1.1 Emulate Details
2.1.2 Emulate Major Business
2.1.3 Emulate Heart-on-a-chip Product and Solutions
2.1.4 Emulate Recent Developments and Future Plans
2.2 Tissuse
2.2.1 Tissuse Details
2.2.2 Tissuse Major Business
2.2.3 Tissuse Heart-on-a-chip Product and Solutions
2.2.4 Tissuse Recent Developments and Future Plans
2.3 Hesperos
2.3.1 Hesperos Details
2.3.2 Hesperos Major Business
2.3.3 Hesperos Heart-on-a-chip Product and Solutions
2.3.4 Hesperos Recent Developments and Future Plans
2.4 CN Bio Innovations
2.4.1 CN Bio Innovations Details
2.4.2 CN Bio Innovations Major Business
2.4.3 CN Bio Innovations Heart-on-a-chip Product and Solutions
2.4.4 CN Bio Innovations Recent Developments and Future Plans
2.5 Draper Laboratory
2.5.1 Draper Laboratory Details
2.5.2 Draper Laboratory Major Business
2.5.3 Draper Laboratory Heart-on-a-chip Product and Solutions
2.5.4 Draper Laboratory Recent Developments and Future Plans
2.6 Mimetas
2.6.1 Mimetas Details
2.6.2 Mimetas Major Business
2.6.3 Mimetas Heart-on-a-chip Product and Solutions
2.6.4 Mimetas Recent Developments and Future Plans
2.7 Nortis
2.7.1 Nortis Details
2.7.2 Nortis Major Business
2.7.3 Nortis Heart-on-a-chip Product and Solutions
2.7.4 Nortis Recent Developments and Future Plans
2.8 Kirkstall
2.8.1 Kirkstall Details
2.8.2 Kirkstall Major Business
2.8.3 Kirkstall Heart-on-a-chip Product and Solutions
2.8.4 Kirkstall Recent Developments and Future Plans
2.9 Cherry Biotech SAS
2.9.1 Cherry Biotech SAS Details
2.9.2 Cherry Biotech SAS Major Business
2.9.3 Cherry Biotech SAS Heart-on-a-chip Product and Solutions
2.9.4 Cherry Biotech SAS Recent Developments and Future Plans
2.10 Else Else Kooi Laboratory
2.10.1 Else Else Kooi Laboratory Details
2.10.2 Else Else Kooi Laboratory Major Business
2.10.3 Else Else Kooi Laboratory Heart-on-a-chip Product and Solutions
2.10.4 Else Else Kooi Laboratory Recent Developments and Future Plans
2.11 Micronit Microtechnologies B.V.
2.11.1 Micronit Microtechnologies B.V. Details
2.11.2 Micronit Microtechnologies B.V. Major Business
2.11.3 Micronit Microtechnologies B.V. Heart-on-a-chip Product and Solutions
2.11.4 Micronit Microtechnologies B.V. Recent Developments and Future Plans
2.12 Tara Biosystems
2.12.1 Tara Biosystems Details
2.12.2 Tara Biosystems Major Business
2.12.3 Tara Biosystems Heart-on-a-chip Product and Solutions
2.12.4 Tara Biosystems Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Heart-on-a-chip Revenue and Share by Players (2024 & 2030)
3.2 Heart-on-a-chip Players Head Office, Products and Services Provided
3.3 Heart-on-a-chip Mergers & Acquisitions
3.4 Heart-on-a-chip New Entrants and Expansion Plans
4 Global Heart-on-a-chip Forecast by Region
4.1 Global Heart-on-a-chip Market Size by Region: 2024 VS 2030
4.2 Global Heart-on-a-chip Market Size by Region, (2024-2030)
4.3 North America
4.3.1 Key Companies of Heart-on-a-chip in North America
4.3.2 Current Situation and Forecast of Heart-on-a-chip in North America
4.3.3 North America Heart-on-a-chip Market Size and Prospect (2024-2030)
4.4 Europe
4.4.1 Key Companies of Heart-on-a-chip in Europe
4.4.2 Current Situation and Forecast of Heart-on-a-chip in Europe
4.4.3 Europe Heart-on-a-chip Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
4.5.1 Key Companies of Heart-on-a-chip in Asia-Pacific
4.5.2 Current Situation and Forecast of Heart-on-a-chip in Asia-Pacific
4.5.3 Asia-Pacific Heart-on-a-chip Market Size and Prospect (2024-2030)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Heart-on-a-chip in South America
4.6.2 Current Situation and Forecast of Heart-on-a-chip in South America
4.6.3 South America Heart-on-a-chip Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
4.7.1 Key Companies of Heart-on-a-chip in Middle East & Africa
4.7.2 Current Situation and Forecast of Heart-on-a-chip in Middle East & Africa
4.7.3 Middle East & Africa Heart-on-a-chip Market Size and Prospect (2024-2030)
5 Market Size Segment by Type
5.1 Global Heart-on-a-chip Market Forecast by Type (2024-2030)
5.2 Global Heart-on-a-chip Market Share Forecast by Type (2024-2030)
6 Market Size Segment by Application
6.1 Global Heart-on-a-chip Market Forecast by Application (2024-2030)
6.2 Global Heart-on-a-chip Market Share Forecast by Application (2024-2030)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Tara Biosystems
Ìý
Ìý
*If Applicable.